CLINICAL_TRIALS
trial_result
· 2024-08-06
Clinical Trial Update: IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Lower Grade Glioma [Phase 1]
Summary
Phase 1 study of the imaging agent IRDye800CW-BBN for guiding surgery in lower-grade glioma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Deling Li | Conditions: Glioma | Phase 1 | Status: COMPLETED